LIVN Q2 2022 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$254M-3.9% YoY

Gross Profit

$184M72.5% margin

Operating Income

$32M12.5% margin

Net Income

$16M6.5% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$16M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.1B

Stockholders' Equity

$1.3B

Cash & Equivalents

$407M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$254M	$264M	-3.9%
Gross Profit	$184M	$172M	+7.0%
Operating Income	$32M	-$36M	+187.6%
Net Income	$16M	-$56M	+129.1%

Revenue Segments

Cardiopulmonary Segment

$126M50%

Neuromodulation Segment

$118M47%

Advanced Circulatory Support Segment

$9M4%

Geographic Segments

UNITED STATES

$138M54%

Locations Excluding The United States And Europe

$69M27%

Europe

$47M19%